The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation
Seminars in Immunopathology · 2025-12 · 47 (1)
DOI: 10.1007/s00281-024-01026-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, online erschienen am 26.11.2024. Verfasst von Ryu Okumura und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan. Hauptthemen laut MEDLINE: Intestinal Mucosa, Symbiosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Osaka University.
Abstract (Originalsprache)
In the intestinal tract, where numerous intestinal bacteria reside, intestinal epithelial cells produce and release various antimicrobial molecules that form a complex barrier on the mucosal surface. These barrier molecules can be classified into two groups based on their functions: those that exhibit bactericidal activity through chemical reactions, such as antimicrobial peptides, and those that physically hinder bacterial invasion, like mucins, which lack bactericidal properties. In the small intestine, where Paneth cells specialize in producing antimicrobial peptides, the chemical barrier molecules primarily inhibit bacterial growth. In contrast, in the large intestine, where Paneth cells are absent, allowing bacterial growth, the primary defense mechanism is the physical barrier, mainly composed of mucus, which controls bacterial movement and prevents their invasion of intestinal tissues. The expression of these barrier molecules is regulated by metabolites produced by bacteria in the intestinal lumen and cytokines produced by immune cells in the lamina propria. This regulation establishes a defense mechanism that adapts to changes in the intestinal environment, such as alterations in gut microbial composition and the presence of pathogenic bacterial infections. Consequently, when the integrity of the gut mucosal barrier is compromised, commensal bacteria and pathogenic microorganisms from outside the body can invade intestinal tissues, leading to conditions such as intestinal inflammation, as observed in cases of inflammatory bowel disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan.
- WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, 565-0871, Japan.
- Institute for Open and Transdisciplinary Research Initiative, Osaka University, Suita, Osaka, 565-0871, Japan.
- Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan. ktakeda@ongene.med.osaka-u.ac.jp.
- WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka, 565-0871, Japan. ktakeda@ongene.med.osaka-u.ac.jp.
- Institute for Open and Transdisciplinary Research Initiative, Osaka University, Suita, Osaka, 565-0871, Japan. ktakeda@ongene.med.osaka-u.ac.jp.
Förderung
- Japan Society for the Promotion of Science
- Osaka University
Zitieren
APA
Okumura, R., & Takeda, K. (2025). The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation. Seminars in Immunopathology, 47(1). https://doi.org/10.1007/s00281-024-01026-5
Vancouver
Okumura R, Takeda K. The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation. Seminars in Immunopathology. 2025;47(1). doi:10.1007/s00281-024-01026-5
BibTeX
@article{Okumura2025,
author = {Okumura, Ryu and Takeda, Kiyoshi},
title = {The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation},
journal = {Seminars in Immunopathology},
year = {2025},
volume = {47},
number = {1},
doi = {10.1007/s00281-024-01026-5}
}
EUVIMED